Human neutrophil peptides and phagocytic deficiency in bronchiectatic lungs

Stefanos Voglis1, Kieran Quinn, Elizabeth Tullis

  • 1The Keenan Research Centre, Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, Ontario, Canada.

Abstract

Insights

Human neutrophil peptides (HNP) in cystic fibrosis (CF) lungs impair neutrophil function, explaining persistent bacterial infections. This interaction suggests HNP as a therapeutic target for inflammatory lung diseases.

Area of Science:

  • Immunology
  • Pulmonology
  • Microbiology

Background:

  • Cystic fibrosis (CF) patients exhibit persistent lung bacterial infections despite abundant neutrophils and human neutrophil peptides (HNP).
  • The mechanisms behind this clinical paradox, where expected antimicrobial agents fail, remain unclear.

Purpose of the Study:

  • To investigate the mechanisms underlying the paradox of persistent bacterial infections in CF lungs.
  • To examine the interaction between neutrophils and HNP and its effect on bacterial clearance.

Main Methods:

  • Polymorphonuclear neutrophils (PMN) were isolated from CF and non-CF bronchiectasis patients' sputum and blood.
  • Phagocytic assays were performed on isolated PMN and on healthy PMN stimulated with HNP from CF patients.
  • Animal models (Pallid mice) were used to study HNP effects on PMN lung infiltration and phagocytosis.

Main Results:

  • PMN from bronchiectatic patients' sputum showed defective phagocytosis, correlating with high lung HNP concentrations.
  • Incubation of healthy PMN with HNP reduced phagocytic capacity by affecting Fc gamma RIII, actin remodeling, intracellular Ca(2+), and degranulation.
  • HNP-induced phagocytic deficiency was mitigated by blocking intracellular Ca(2+) or using alpha1-proteinase inhibitor; HNP instillation in mice led to increased PMN infiltration and phagocytic deficiency.

Conclusions:

  • The interaction between HNP and PMN diminishes their individual antimicrobial capabilities, explaining the paradox in CF and other inflammatory lung diseases.
  • Human neutrophil peptides (HNP) represent a potential novel therapeutic target for managing persistent lung infections in inflammatory lung diseases.

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...